Oral 5‐ASA vs 5‐aminosalicylic acid (5‐ASA) (mesalazine)
Failure to induce endoscopic remission · Patients with active mild to moderate ulcerative colitis
The review found no eligible studies for this question.
1 finding from 1 review
- Oral 5‐aminosalicylic acid for induction of remission in ulcerative colitis 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found